Monday, November 16, 2020

Carlyle's COVID Profit Plans


The Carlyle Group intends to profit from the global pandemic.  Carlyle's website states:

While the healthcare industry has permanently changed by the COVID-19 pandemic, it has also accelerated key themes that our Global Healthcare team has been consistently focused on for years.

Three healthcare industry themes that we believe have been accelerated by the coronavirus pandemic: 

  1. Increased emphasis on diversified healthcare delivery  (Brazilian hospital operator Rede D'or Sao Luis)
  2. A shift toward digital innovation and digital disruption (Grand Rounds, OneMedical)
  3. The importance of the bio-pharmaceutical revolution  (TriNetX, PPD, Albany Molecular Research, Piramal)

Carlyle failed to mention the other ways it plans to profit from COVID-19.

Carlyle affiliates can conduct retrospective studies on COVID-19 (TriNetX), disinfect surfaces (Victory Innovations), screen airports for people with fever (Schneider Electric & HGH), test for COVID antibodies (Ortho Clinical), assist with blood plasma collection (MAK Systems), produce antibody drug conjugate (Piramal Pharma Solutions), ensure the maximum hospital bill for COVID-19 patients (TrustHCS), manufacture Ivermectin treatment (SeQuent Scientific) and make federal coronavirus purchasing something other than a clown show (Unison). 

Coronavirus tea leaves suggest more PEU profits to come.  Those leave can be wrong.  Recall Carlyle drove LifeCare Hospitals and nursing home giant ManorCare into bankruptcy. 

More investment by the greed and leverage boys is not a good sign for people struggling to pay for healthcare in the United States.  

Update 3-13-21:  The former PECKER Council highlighted PEU entries in COVID-19 care.  PECKER is an abbreviation for Private Equity Capital Knowledge Executed Responsibly.

Update 6-9-24:  Carlyle exited Brazilian hospital operator Rede D'Or.

Sunday, November 15, 2020

Carlyle to Flip Supreme


GQ reported:

Denver-based VF Corporation, which owns Supreme collaborators like The North Face, Timberland, and Vans, as well as workwear brands like Dickies and Napapijri, announced this morning that it will acquire Supreme for $2.1 billion. Supreme’s current investors, The Carlyle Group and Goode Partners, will sell their stakes. You may recall that Carlyle paid $500 million for a 50% stake in Supreme back in 2017; as one writer has already joked, this makes The Carlyle Group the world’s most successful Supreme reseller.

Carlyle's website never listed Supreme as an affiliate.  It did not post stories on its purchase or planned sale of Supreme.  Private equity is contrary to streetwear cool.  That discord grew when Carlyle owned flashbangs and pepper munitions were used on peaceful protesters. 

Carlyle will make at least a double on its Supreme investment.  Depending on the mix of debt and equity the profit multiple could be far higher than a simple 2X.

Supreme will be leaving as The Carlyle Group at an interesting time.  There is a pandemic from which to profit.  

Wednesday, November 11, 2020

Blue PEU Klain Biden's Chief of Staff

 

President Elect Joe Biden chose Ron Klain as his White House Chief of Staff.  Klain is Executive Vice President and General Counsel for Revolution LLC.  Revolution LLC is considered a venture capital/private equity firm.  

PEUReport ran pieces on Klain, the first in 2014 when he was named the Ebola Czar with no public health background.  The second story ran in 2016 when Klain chose Hillary over Biden. 

It's been a little hard for me to play such a role in the Biden demise - and I am definitely dead to them -- but I'm glad to be on Team HRC.

Somehow Candidate Joe Biden forgave Ron and his political rebirth came in a Biden "Here's the Deal" March 2020 podcast. 

Politicians Red and Blue love PEU.  The appointment of Ron Klain as Chief of Staff shows the greed and leverage boys remain firmly entrenched in America's Government-Corporate Monstrosity.

Update 11-12-20:  Revolution LLC's Steve Case presented with The Carlyle Group's David Rubenstein at the Rise of the Rest CEO Summit in November 2019.   Rubenstein should continue his preferred access to the White House under Biden and Chief of Staff Klain.  Also, two potential Biden cabinet members were at the event, Eric Schmidt and Meg Whitman.

"We've become, now, an oligarchy instead of a democracy. I think that's been the worst damage to the basic moral and ethical standards to the American political system that I've ever seen in my life." -- Jimmy Carter

Update 11-19-20:   Erin Brokovich wrote a letter to President Elect Joe Biden chastising him for putting a former DuPont consultant on his EPA Transition Board.  It's a different kind of PEU.

Update 10-14-21:  Biden Chief of Staff Klain believes inflation and supply chain problems only impact wealthy.  That's patently laughable.  

Thursday, November 5, 2020

Jack Ma's Free Speech Hurt Ant Financial IPO, Carlyle Impacted


 Reuters reported:

Corporate China's shiniest star was just days away from seeing his Ant Group list on the stock market in a record $37 billion deal, when he chose to launch a blistering public attack on the country's financial watchdogs and banks.

The regulatory system was stifling innovation and must be reformed to fuel growth, billionaire Ma told a summit in Shanghai on Oct. 24 attended by the great and the good of China's financial, regulatory and political establishment.

Stung by the attack, Chinese regulators and Communist Party officials set about reining in Ma's sprawling financial empire, culminating in the suspension of the IPO on Tuesday, two days before the eagerly awaited market debut in Shanghai and Hong Kong, the sources said.

The Carlyle Group invested in Ant Financial in May 2018 joining other investors in a $10 billion round which valued Ant at $150 billion. TechCrunch reported:

Ant would have sported a possible market valuation of more than $300 billion at its IPO price. Such a valuation would rank it amongst the most valuable companies in the world.

Carlyle's double is delayed at least six months according to FT.

The Carlyle Group's co-founder David Rubenstein built his vast fortune catering to the world's political elite, even employing some of them.  Will Rubenstein try to smooth over Ant Financial's turbulent waters?  Might he coach Jack Ma in the art of apology, given his history with Carlyle Capital Corporation and an angry Kuwait SWF?  

It will be interesting to see how much Ma's honesty costs Carlyle in the end.  

Update 11-12-20:  Chinese President Xi pulled Ant's IPO according to the WSJ.  That will take some serious apology horsepower.  

Update 1-21-20:  Carlyle's big payday from Ant is in jeopardy.

Update 2-9-21:   There is no timeline for Carlyle to cash in on its Ant investment.

Update 3-18-21:  Investor valued Ant Holdings at over $200 billion, down from $315 billion in the run up to the planned IPO.

Update 9-3-21:  Carlyle co-founder David Rubenstein spoke to the situation Ant Financial faces with the Chinese government in a Bloomberg interview.  He said the problem arose from entrepreneurs, like Jack Ma, becoming larger than government officials in the public sphere.

Update 9-13-21:  "Any wealthy person with an ounce of sense is keeping silent and bowing their heads, to avoid political fire, and in subservience to the Chinese Communist Party."  

Update 10-25-21:  Alibaba lost a whopping $344 billion in market capitalization.  The biggest wipe-out of shareholder value globally came after Beijing suspended the listing of its fintech arm Ant Group.

Sunday, October 11, 2020

Milken Global Institute Starts 10-12


The Milken Global Institute, the U.S. version of Davos, begins tomorrow.  This is the first gathering since President Donald Trump pardoned junk bond king Michael Milken.  The theme is "Meeting the Moment."  How can those in positions of power continue to steer the system to their advantage during dual crises, a global pandemic and racial injustice?   That is the unstated objective of most Institute sponsors.  Two Institute sponsors recently admitted to breaking the law, Citadel and Citigroup. 

Politicians Red and Blue love PEU and the speaker list is full of high profile Republicans and Democratic names.  The Red Team has Treasury Secretary Steve Mnuchin, Education Secretary Betsy DeVos, FDA Chief Stephen Hahn and Republican political advisor Frank Luntz.  The Blue Team has a broader showing with John Kerry, Senators Mark Warner and Chris Coons, Congressman James Clyburn, and former Obama officials Eric Holder and Susan Rice.

Carlyle Group CEO Kewsong Lee will be in a panel on "Leadership:  Moving Beyond Conventional Thinking".  Moderator Andy Serwer will tackle:

Even before the pandemic, the need for agility and constant innovation had become evident as technology disrupted every sector. How can you foster entrepreneurial spirit within corporate structures and ensure creative destruction? And how can leaders motivate others to embrace the need for constant transformation?

The Carlyle Group schooled on COVID-19 via its Chinese medical holdings and began to compile a coronavirus portfolio in February.

Carlyle affiliates can conduct retrospective studies on COVID-19 (TriNetX), disinfect surfaces (Victory Innovations), screen airports for people with fever (Schneider Electric & HGH), test for COVID antibodies (Ortho Clinical), assist with blood plasma collection (MAK Systems), produce antibody drug conjugate (Piramal Pharma Solutions), ensure the maximum hospital bill for COVID-19 patients (TrustHCS), manufacture Ivermectin treatment (SeQuent Scientific) and make federal coronavirus purchasing something other than a clown show (Unison).  Coronavirus tea leaves suggest more PEU profits to come.

The Milken Global Institute will continue enriching the rich and empowering the powerful.  It's the PEU way.

Update 10-13-20:  Apollo founder Leon Black sent a letter to investors expressing his regret for associating with Jeffrey Epstein. 

Update 10-14-20:  Treasury Secretary Mnuchin commented on the stimulus package delay from Milken Global Institute.  Dealbook reported how private White House meetings helped the greed and leverage boys make big money as the pandemic hit the U.S.

Update 10-17-20:  Vista Equity founder Robert Smith reached a $140 million settlement with the Justice Department for tax evasion.  More greed from the PEU boys.

Update 10-28-20:  More problems at Vista Equity Partners from the firm's PEU ways.  Fed money for Main Street goes unused as the PEU boys run dividend recaps on affiliates, debt for sponsor dividends.  Insider trading is rampant with no accountability or oversight.

Update 12-31-21:  A jury found Epstein accomplice Ghislaine Maxwell guilty of sex trafficking underage girls. She may now have an incentive to turn over Leon Black, Bill Clinton, Tony Blair, Prince Andrew and other high profile sexual predators.

FT's report on Milken's meeting is nearly cringe-worthy.  Found it while looking to see if Milken ever flew on Jeffrey Epstein's plane.

Update 3-6-22:  Vista Equity's Robert Smith played a larger role in the $2 billion tax avoidance scheme by his partner. 

Friday, September 25, 2020

Carlyle Adds Two COVID-19 Investments, TriNetX and Victory Innovations

 

The Carlyle Group added disinfecting equipment maker Victory Innovations and research organization TriNetX to its substantial coronavirus profit portfolio.  The private equity underwriter (PEU) took a majority stake in both firms and did not share transaction details.

TriNetX raised $40 million in March 2019 to fund growth.  March 2020 saw the coronavirus hit the U.S. Northeast hard.   

TriNetX enables researchers to apply a data-driven approach to health research by providing web-based, on-demand access to harmonized global electronic health record (EHR) and claims data


TriNetX sounds similar to recently disgraced Surgisphere, which withdrew a COVID-19 paper from The Lancet due to data intergrity questions.  Science reported:

Surgisphere founder Sapan Desai publicly aspired to combine big data and artificial intelligence (AI) in ways that he said can replace randomized controlled clinical trials. For a brief moment, it seemed that Surgisphere’s enticing data set, said to include nearly 100,000 detailed patient records from about 700 hospitals on six continents, would settle questions about the possible benefits of various drugs—including the controversial antimalarial hydroxychloroquine—for COVID-19 patients. 

Carlyle's press release quoted TriNetX CEO Gadi Lachman.

CEO Gadi Lachman added "To accomplish this we need to continue to develop solutions to support clinical research at our healthcare organizations and bring more global data and technologies such as AI, machine learning and analytics to researchers so that they can ask more questions and generate more real-world evidence. Carlyle's investment accelerates our growth plans and will shorten the time it takes to turn our vision into reality." 

Carlyle schooled on the coronavirus via its Chinese medical holdings.  President Trump's lingering inaction means many more cases to come, thus more Carlyle Group profits.  

Carlyle affiliates can conduct retrospective studies on COVID-19 (TriNetX), disinfect surfaces (Victory Innovations), screen airports for people with fever (Schneider Electric & HGH), test for COVID antibodies (Ortho Clinical), assist with blood plasma collection (MAK Systems), produce antibody drug conjugate (Piramal Pharma Solutions), ensure the maximum hospital bill for COVID-19 patients (TrustHCS), manufacture Ivermectin treatment (SeQuent Scientific) and make federal coronavirus purchasing something other than a clown show (Unison).  Coronavirus tea leaves suggest more PEU profits to come.

Sunday, September 6, 2020

Rubenstein's PEU Life: How to Greed


Carlyle Group co-founder David Rubenstein authored the book "How to Lead:  Wisdom from the World's Greatest CEOs, Founders and Game Changers."  Rubenstein pioneered private equity, the practice of buying companies with borrowings and flipping them for huge gains on the initial equity investment.  He helped innovate the offering of additional debt for an affiliate company in order to pay Carlyle a monster dividend.  His achievements in the greed arena are not in his book. 

“I’m not a journalist,” Rubenstein says. “My job is not to ask questions that might embarrass somebody … people can judge whether that’s a good or bad thing.

“The people that I interview are people that I have known, generally, for a reasonably long time. So the appeal of it is they feel comfortable with me, and they might be willing to say some things they might not to a professional journalist. And here’s the cost of that: I won’t ask the embarrassing questions, because they won’t expect it from me.

Rubenstein does not ask the tough questions because he does not allow such questioning in his financial media interviews.   Secretary of State Mike Pompeo told Rubenstein in a friendly chat:

Trump is “very focused on where the money is, and how we use economic leverage to achieve our diplomatic ends”.

Rubenstein has a laser like focus on the money, as well.  His ex-wife gave a less than charitable assessment while they were still married:

In 2016, Rubenstein gave the National Park Service $18.5 million to help restore the Lincoln Memorial. In private, Alice Rogoff Rubenstein has described those acts as publicity grabs and claimed all her financier husband really cares about is making money. 

Supreme Court Justice Ruth Bader Ginsberg quoted Judge Learned Hand:

‘If the fire dies in the hearts of the people, no constitution and no judge can restore it.’ My faith is in the spirit of liberty.”

Private equity crushed the hearts of many people.  Consider this 2011 statement from a journalist with a major financial media company.

I have seen so many people -- particularly those in their 50s - 70s -- taken apart by what has happened in their industry as greed has hollowed out the economy. These are people took pride in their jobs and held themselves to this invisible standard that we all just took for granted, but is being wiped out.

The Carlyle Group scares me more than anything I've ever seen on Wall Street. It seems to exist to corrupt politicians and it's hard to know who they even represent.

I watched a video interview of (David) Rubenstein and his arrogance is really beyond tolerance. He was going on about the debt ceiling problem and how there would need to be cuts in services and higher taxes. When the reporter asked him about tax on carried interest he turned really disdainful and said that this "only" amounted to $22 billion over some number of years and this was not serious money. Boy, nothing like everybody doing their small part to save the country from oblivion!

Carlyle's David Rubenstein fought very hard over more than a decade to keep private equity's preferred taxation. There is another book to write about the greed and leverage boys and the damage they've done to the spirit of our country.   

Rubenstein recently said private company CEOs are realizing they won't need as many workers as they once thought.  That is part of Carlyle's PEU insight, marketed as OneCarlyle.  Rubenstein ignored Yahoo Finance's Andy Serwer when asked if he would donate to any groups helping millions of unemployed Americans.   

For decades Carlyle has counted on the U.S. government and officials in both political parties.  The financial media learned long ago not to challenge Rubenstein.  His billionaire status, patriotic philanthropy connections and authorship have his face all over the general media.

I don't know how you write a book on leadership and. when asked. not eviscerate Donald Trump for failing to meet the basics of compassion, empathy, integrity and competence.   David Rubenstein can.